Video Experimental Relacionado

Updated: Feb 24, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Irisina, Esclerostina y Eje Inflamatorio: Implicación en Enfermedades de Desgaste Óseo-Muscular

Mohamad Maged¹, Sameh Heikal¹, Salma Ibrahim²

¹Applied Biotechnology Program, School of Biotechnology, Nile University, Giza, Egypt.

Cell biochemistry and function

|February 23, 2026

Resumen

Las poblaciones que envejecen se enfrentan a un aumento de las enfermedades óseo-musculares como la osteoporosis y la sarcopenia. Esta revisión detalla la tríada irisina-esclerostina-inflamación

Área de la Ciencia:

Salud Musculoesquelética
Investigación sobre el Envejecimiento
Biología Molecular

Sus antecedentes:

Las enfermedades óseo-musculares (osteoporosis, sarcopenia) están aumentando a nivel mundial, especialmente en adultos mayores.
Estas afecciones implican la disminución de la densidad ósea y la masa muscular, lo que conduce a la inmovilidad.
Las complejas interacciones moleculares entre el hueso y el músculo impulsan estos trastornos.

Objetivo del estudio:

Revisar el papel de la tríada irisina-esclerostina-inflamación en la degeneración musculoesquelética.
Explorar las correlaciones entre estas enfermedades, mediadores, edad y sexo.
Discutir las estrategias terapéuticas actuales y emergentes dirigidas a esta tríada.

Principales métodos:

Revisión de la literatura centrada en la tríada irisina-esclerostina-inflamación.
Análisis de la comunicación molecular en los trastornos de desgaste óseo-muscular.
Examen de las intervenciones terapéuticas y las prioridades de investigación futuras.

Principales resultados:

La irisina (miokina) promueve la osteogénesis y la regeneración muscular.
La esclerostina (antagonista de Wnt) inhibe la formación ósea y perjudica la regeneración muscular.
Los mediadores inflamatorios (TNF-α, IL-6) impulsan el catabolismo muscular y la resorción ósea a través de las vías NF-κB y STAT3.

Conclusiones:

La desregulación de la tríada irisina-esclerostina-inflamación acelera la degeneración musculoesquelética.
Las estrategias terapéuticas incluyen anticuerpos anti-esclerostina, inhibidores de citoquinas y ejercicio.
La estandarización de los ensayos y las terapias combinadas de precisión son cruciales para los trastornos de desgaste óseo-muscular.

Palabras clave:

IL-6 Irisina TNF-α interacción óseo-muscular enfermedades musculoesqueléticas esclerostina

Videos de Conceptos Relacionados

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

The Functions of the Skeletal System

The Functions of the Skeletal System

The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...